Evidence map›Paper›PMID 17968319›Full record

ArticleOncogene2008

Immortalization of epithelial progenitor cells mediated by resveratrol.

V P Pearce, J Sherrell, Z Lou, L Kopelovich, W E Wright, J W Shay

Abstract read
In one paragraph

Article in Oncogene, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Ascorbic Acid Attenuates Senescence of Human Osteoarthritic Osteoblasts.International journal of molecular sciences · 2017
    Article
  8. Management of suspected monogenic lung fibrosis in a specialised centre.European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
  9. Tissue Distribution ofJournal of ophthalmology · 2017
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Challenges of translating basic research into therapeutics: resveratrol as an example.The journals of gerontology. Series A, Biological sciences and medical sciences · 2012
    Article
  18. Pharmaceutical regulation of telomerase and its clinical potential.Journal of cellular and molecular medicine · 2012
    Review
  19. Medical genetics and epigenetics of telomerase.Journal of cellular and molecular medicine · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

V P PearceDepartment of Pharmacology and Neuroscience, UNT Health Science Center at Fort Worth, University of North Texas, Fort Worth, TX, USA.
J Sherrell
Z Lou
L Kopelovich
W E Wright
J W Shay
University of North Texas · USNational Cancer Institute · USThe University of Texas Southwestern Medical Center · USUniversity of Arizona · USUniversity of North Texas at Dallas · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BYERS, LAUREN AVERETT · 1996 to 2024
$57.4M
MECHANISM-BASED IN VITRO SCREENING OF CHEMOPREVENTIVE AGN01CN005106 · CN · STRANG CANCER PREVENTION CENTER · PI LIPKIN, MARTIN · 2000 to 2000
$498k
HERITABLE FACTORS GOVERNING MELANOMA SUSCEPTIBILITYR03CA075907 · NCI · WISTAR INSTITUTE · PI LINNENBACH, ALBAN J · 1997 to 1997
–
NCI NIH HHS CN-05106NCI NIH HHS N01 CN043301NCI NIH HHS N01-CN43301NCI NIH HHS P50 CA070907NCI NIH HHS P50 CA75907
6 · The paper itself

Abstract

Within the hierarchy of epithelial stem cells, normal progenitor cells may express regulated telomerase during renewal cycles of proliferation and differentiation. Discontinuous telomerase activity may promote increased renewal capacity of progenitor cells, while deregulated/continuous telomerase activity may promote immortalization when differentiation and/or senescent pathways are compromised. In the present work, we show that resveratrol activates, while progesterone inactivates, continuous telomerase activity within 24 h in subpopulations of human Li-Fraumeni syndrome-derived breast epithelial cells. Resveratrol results in immortalization of mixed progenitor cells with mutant p53, but not human epithelial cells with wild type p53. Our results demonstrate the potential for renewing progenitor cells with mutant p53 to immortalize after continuous telomerase expression when exposed to certain environmental compounds. Understanding the effects of telomerase modulators on endogenous telomerase activity in progenitor cells is relevant to the role of immortalization in the initiation and progression of cancer subtypes.

Indexed as

AdultCells, CulturedCell SeparationCell SurvivalEnzyme ActivationEpithelial CellsFemaleHumansProgesteroneReceptors, EstrogenResveratrolStem CellsStilbenesTelomeraseProgesteroneReceptors, EstrogenResveratrolStilbenesTelomerase

Identifiers

PMID17968319
PMCPMC3397201
OpenAlexW2142021077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.